Acción 1783 MAXIGEN BIOTECH INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Maxigen Biotech Inc.

Acciones

1783

TW0001783009

Precio de cierre Taiwan S.E.
Otros sitios de cotización
 00:00:00 01/07/2024 		Varia. Cinco días. Varia. 1 de enero.
50,2 TWD +8,66 % Gráfico intradía de Maxigen Biotech Inc. +8,42 % +3,72 %
06/05 Maxigen Biotech Inc. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024 CI
03/05 Maxigen Biotech Inc. Anuncia Dividendo en Efectivo para el Periodo del 1 de Enero de 2023 al 31 de Diciembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Maxigen Biotech Inc. Announces Cash Dividend for the Period from January 1, 2023 to December 31, 2023
Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Maxigen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Maxigen Biotech Inc.(TWSE:1783) added to S&P Global BMI Index
Maxigen Biotech Inc. Declares Dividend, Payable on October 12, 2023
Maxigen Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Maxigen Biotech Inc. Announces Cash Dividend for the Period from January 1, 2022 to December 31, 2022
Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Maxigen Biotech Inc. Announces Executive Changes
Maxigen Biotech Inc. Reports Consolidated Revenues Results for the Month and Year to Date Ended December 2022
Maxigen Biotech Inc. Announces Resignation of You Wan-How as Financial Officer and Accounting Officer
Maxigen Biotech Inc. Reports Consolidated Revenues Results for the Month and Year to Date Ended November 2022
Maxigen Biotech Inc. Reports Consolidated Revenues Results for the Month and Year to Date Ended October 2022
Maxigen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Maxigen Biotech Inc. Reports Consolidated Revenue Results for the Month and Year-To-Date Ended September 2022
Maxigen Biotech : Monthly revenue report, July 2022
Maxigen Biotech Inc. Reports Consolidated Revenue Results for the Month and Year-to-Date Ended July 2022
Maxigen Biotech : Board of Directors' Resolution for the change of the chief internal auditor
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 1783
  4. Noticias Maxigen Biotech Inc.
  5. Otros idiomas